Skip to main content
Top
Published in: Drugs in R&D 1/2019

Open Access 01-03-2019 | Metformin | Original Research Article

Assessment of Taste and Grittiness of Riomet® ER Strawberry, Riomet® ER Grape, Riomet® Cherry, and Metformin Immediate-Release Tablets in Healthy Subjects

Authors: Allyson C. Marshall, Maureen Damstra, Michael Tuley, Elena L. Schifando

Published in: Drugs in R&D | Issue 1/2019

Login to get access

Abstract

Objective

This study was conducted to evaluate the taste and grittiness of two formulations of Riomet® ER (metformin hydrochloride for extended release [ER] oral suspension 100 mg/mL) differing only in their flavoring agents (strawberry and grape) in comparison with two commercially available immediate-release (IR) formulations of metformin, Riomet® Cherry (metformin hydrochloride oral solution 500 mg/5 mL) and metformin IR tablets (metformin hydrochloride IR tablets 500 mg), in healthy human subjects aged 10–70 years.

Methods

Five comparison sets (i.e., Riomet® Cherry vs. Riomet® ER Strawberry; Riomet® Cherry vs. Riomet® ER Grape; metformin IR vs. Riomet® ER Strawberry; metformin IR vs. Riomet® ER Grape; and Riomet® Cherry vs. metformin IR) were evaluated. Riomet® ER was reconstituted as instructed on the label. Metformin IR tablets were crushed one at a time into a fine powder using a pharmaceutical pill crusher and mixed with 5 mL of water. A 2.5-mL dose of each product was administered to each subject. Subjects were instructed not to swallow any of the products. Each product in the comparison set was rated by the subjects for taste and grittiness according to a 7-point hedonic facial scale and a 5-point level of agreement scale. A comparison questionnaire was also completed by the subjects after evaluating each set. In all, 56 subjects were enrolled and 55 subjects completed the study. The taste preference was statistically evaluated.

Results and Conclusions

All Riomet® formulations were significantly preferred overall to metformin IR crushed tablets. Both the strawberry and the grape flavors of Riomet® ER tended to be preferred to Riomet® Cherry.
Appendix
Available only for authorised users
Literature
1.
go back to reference Demmer RT, Zuk AM, Rosenbaum M, Desvarieux M. Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999–2010. Am J Epidemiol. 2013;178(7):1106–13.PubMedPubMedCentralCrossRef Demmer RT, Zuk AM, Rosenbaum M, Desvarieux M. Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999–2010. Am J Epidemiol. 2013;178(7):1106–13.PubMedPubMedCentralCrossRef
2.
go back to reference American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef
3.
go back to reference American Diabetes A. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Suppl 1):S73–85.CrossRef American Diabetes A. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Suppl 1):S73–85.CrossRef
4.
go back to reference Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis. JAMA. 2016;316(3):313–24.PubMedCrossRef Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis. JAMA. 2016;316(3):313–24.PubMedCrossRef
5.
go back to reference Hermann LS, Melander A. Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, editors. International textbook of diabetes mellitus, vol. 1. Chichester: Wiley; 1992. p. 773–95. Hermann LS, Melander A. Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, editors. International textbook of diabetes mellitus, vol. 1. Chichester: Wiley; 1992. p. 773–95.
6.
go back to reference Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther. 2008;30(11):2133–45.PubMedCrossRef Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther. 2008;30(11):2133–45.PubMedCrossRef
8.
go back to reference Aslam M, Vaezi MF. Dysphagia in the elderly. Gastroenterol Hepatol (N Y). 2013;9(12):784–95. Aslam M, Vaezi MF. Dysphagia in the elderly. Gastroenterol Hepatol (N Y). 2013;9(12):784–95.
9.
go back to reference Lopez FL, Bowles A, Gul MO, Clapham D, Ernest TB, Tuleu C. Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. Eur J Pharm Sci. 2016;92:156–62.PubMedCrossRef Lopez FL, Bowles A, Gul MO, Clapham D, Ernest TB, Tuleu C. Effect of formulation variables on oral grittiness and preferences of multiparticulate formulations in adult volunteers. Eur J Pharm Sci. 2016;92:156–62.PubMedCrossRef
10.
go back to reference Thompson A, Reader S, Field E, Shephard A. Open-label taste-testing study to evaluate the acceptability of both strawberry-flavored and orange-flavored amylmetacresol/2,4-dichlorobenzyl alcohol throat lozenges in healthy children. Drugs R D. 2013;13(2):101–7.PubMedPubMedCentralCrossRef Thompson A, Reader S, Field E, Shephard A. Open-label taste-testing study to evaluate the acceptability of both strawberry-flavored and orange-flavored amylmetacresol/2,4-dichlorobenzyl alcohol throat lozenges in healthy children. Drugs R D. 2013;13(2):101–7.PubMedPubMedCentralCrossRef
12.
go back to reference Iglay K, Cartier SE, Rosen VM, Zarotsky V, Rajpathak SN, Radican L, et al. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin. 2015;31(7):1283–96.PubMedCrossRef Iglay K, Cartier SE, Rosen VM, Zarotsky V, Rajpathak SN, Radican L, et al. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin. 2015;31(7):1283–96.PubMedCrossRef
13.
go back to reference Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.PubMedCrossRef Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.PubMedCrossRef
14.
go back to reference Nichols GA, Rosales AG, Kimes TM, Tunceli K, Kurtyka K, Mavros P. The change in HbA1c associated with initial adherence and subsequent change in adherence among diabetes patients newly initiating metformin therapy. J Diabetes Res. 2016;2016:9687815.PubMedPubMedCentralCrossRef Nichols GA, Rosales AG, Kimes TM, Tunceli K, Kurtyka K, Mavros P. The change in HbA1c associated with initial adherence and subsequent change in adherence among diabetes patients newly initiating metformin therapy. J Diabetes Res. 2016;2016:9687815.PubMedPubMedCentralCrossRef
15.
go back to reference Farmer AJ, Rodgers LR, Lonergan M, Shields B, Weedon MN, Donnelly L, et al. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: a retrospective cohort analysis in a large primary care database. Diabetes Care. 2016;39(2):258–63.PubMed Farmer AJ, Rodgers LR, Lonergan M, Shields B, Weedon MN, Donnelly L, et al. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: a retrospective cohort analysis in a large primary care database. Diabetes Care. 2016;39(2):258–63.PubMed
16.
go back to reference Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.PubMedCrossRef Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.PubMedCrossRef
17.
go back to reference Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care. 2013;19(3):194–202.PubMedPubMedCentral Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care. 2013;19(3):194–202.PubMedPubMedCentral
18.
go back to reference Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376(15):1419–29.PubMedPubMedCentralCrossRef Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376(15):1419–29.PubMedPubMedCentralCrossRef
19.
go back to reference Hommel KA, Baldassano RN. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J Pediatr Psychol. 2010;35(9):1005–10.PubMedCrossRef Hommel KA, Baldassano RN. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J Pediatr Psychol. 2010;35(9):1005–10.PubMedCrossRef
20.
go back to reference Ingerski LM, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol. 2010;35(6):683–91.PubMedCrossRef Ingerski LM, Baldassano RN, Denson LA, Hommel KA. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol. 2010;35(6):683–91.PubMedCrossRef
21.
go back to reference Modi AC, Zeller MH, Xanthakos SA, Jenkins TM, Inge TH. Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity (Silver Spring). 2013;21(3):E190–5.CrossRef Modi AC, Zeller MH, Xanthakos SA, Jenkins TM, Inge TH. Adherence to vitamin supplementation following adolescent bariatric surgery. Obesity (Silver Spring). 2013;21(3):E190–5.CrossRef
22.
go back to reference Baguley D, Lim E, Bevan A, Pallet A, Faust SN. Prescribing for children—taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–7.PubMedCrossRef Baguley D, Lim E, Bevan A, Pallet A, Faust SN. Prescribing for children—taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–7.PubMedCrossRef
23.
go back to reference Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871–89.PubMedPubMedCentralCrossRef Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871–89.PubMedPubMedCentralCrossRef
24.
25.
go back to reference Marquis J, Schneider MP, Payot V, Cordonier AC, Bugnon O, Hersberger KE, et al. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013;35(6):1130–6.PubMedCrossRef Marquis J, Schneider MP, Payot V, Cordonier AC, Bugnon O, Hersberger KE, et al. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013;35(6):1130–6.PubMedCrossRef
26.
go back to reference Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937–48.PubMedCrossRef Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937–48.PubMedCrossRef
28.
go back to reference Quijano Ruiz B, Desfontaine E, Arenas-Lopez S, Wang S. Pediatric formulation issues identified in paediatric investigation plans. Expert Rev Clin Pharmacol. 2014;7(1):25–30.PubMedCrossRef Quijano Ruiz B, Desfontaine E, Arenas-Lopez S, Wang S. Pediatric formulation issues identified in paediatric investigation plans. Expert Rev Clin Pharmacol. 2014;7(1):25–30.PubMedCrossRef
29.
go back to reference Bourdenet G, Giraud S, Artur M, Dutertre S, Dufour M, Lefebvre-Caussin M, et al. Impact of recommendations on crushing medications in geriatrics: from prescription to administration. Fundam Clin Pharmacol. 2015;29(3):316–20.PubMedCrossRef Bourdenet G, Giraud S, Artur M, Dutertre S, Dufour M, Lefebvre-Caussin M, et al. Impact of recommendations on crushing medications in geriatrics: from prescription to administration. Fundam Clin Pharmacol. 2015;29(3):316–20.PubMedCrossRef
30.
go back to reference Fodil M, Nghiem D, Colas M, Bourry S, Poisson-Salomon AS, Rezigue H, et al. Assessment of clinical practices for crushing medication in geriatric units. J Nutr Health Aging. 2017;21(8):904–8.PubMedCrossRef Fodil M, Nghiem D, Colas M, Bourry S, Poisson-Salomon AS, Rezigue H, et al. Assessment of clinical practices for crushing medication in geriatric units. J Nutr Health Aging. 2017;21(8):904–8.PubMedCrossRef
32.
go back to reference Ranmal SR, Cram A, Tuleu C. Age-appropriate and acceptable paediatric dosage forms: insights into end-user perceptions, preferences and practices from the Children’s Acceptability of Oral Formulations (CALF) Study. Int J Pharm. 2016;514(1):296–307.PubMedCrossRef Ranmal SR, Cram A, Tuleu C. Age-appropriate and acceptable paediatric dosage forms: insights into end-user perceptions, preferences and practices from the Children’s Acceptability of Oral Formulations (CALF) Study. Int J Pharm. 2016;514(1):296–307.PubMedCrossRef
33.
go back to reference Hansen DL, Tulinius D, Hansen EH. Adolescents’ struggles with swallowing tablets: barriers, strategies and learning. Pharm World Sci. 2008;30(1):65–9.PubMedCrossRef Hansen DL, Tulinius D, Hansen EH. Adolescents’ struggles with swallowing tablets: barriers, strategies and learning. Pharm World Sci. 2008;30(1):65–9.PubMedCrossRef
34.
go back to reference Forough AS, Lau ET, Steadman KJ, Cichero JA, Kyle GJ, Serrano Santos JM, et al. A spoonful of sugar helps the medicine go down? A review of strategies for making pills easier to swallow. Patient Prefer Adherence. 2018;12:1337–46.PubMedPubMedCentralCrossRef Forough AS, Lau ET, Steadman KJ, Cichero JA, Kyle GJ, Serrano Santos JM, et al. A spoonful of sugar helps the medicine go down? A review of strategies for making pills easier to swallow. Patient Prefer Adherence. 2018;12:1337–46.PubMedPubMedCentralCrossRef
35.
go back to reference Patel A, Jacobsen L, Jhaveri R, Bradford KK. Effectiveness of pediatric pill swallowing interventions: a systematic review. Pediatrics. 2015;135(5):883–9.PubMedCrossRef Patel A, Jacobsen L, Jhaveri R, Bradford KK. Effectiveness of pediatric pill swallowing interventions: a systematic review. Pediatrics. 2015;135(5):883–9.PubMedCrossRef
36.
go back to reference Polaha J, Dalton WT 3rd, Lancaster BM. Parental report of medication acceptance among youth: implications for everyday practice. South Med J. 2008;101(11):1106–12.PubMedCrossRef Polaha J, Dalton WT 3rd, Lancaster BM. Parental report of medication acceptance among youth: implications for everyday practice. South Med J. 2008;101(11):1106–12.PubMedCrossRef
38.
go back to reference Buckley LA, Salunke S, Thompson K, Baer G, Fegley D, Turner MA. Challenges and strategies to facilitate formulation development of pediatric drug products: safety qualification of excipients. Int J Pharm. 2018;536(2):563–9.PubMedCrossRef Buckley LA, Salunke S, Thompson K, Baer G, Fegley D, Turner MA. Challenges and strategies to facilitate formulation development of pediatric drug products: safety qualification of excipients. Int J Pharm. 2018;536(2):563–9.PubMedCrossRef
39.
go back to reference Zajicek A, Fossler MJ, Barrett JS, Worthington JH, Ternik R, Charkoftaki G, et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS J. 2013;15(4):1072–81.PubMedPubMedCentralCrossRef Zajicek A, Fossler MJ, Barrett JS, Worthington JH, Ternik R, Charkoftaki G, et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS J. 2013;15(4):1072–81.PubMedPubMedCentralCrossRef
40.
go back to reference Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R, et al. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014;73:14–33.PubMedCrossRef Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R, et al. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014;73:14–33.PubMedCrossRef
41.
go back to reference Mistry P, Batchelor H. Methodology used to assess acceptability of oral pediatric medicines: a systematic literature search and narrative review. Paediatr Drugs. 2017;19(3):223–33.PubMedCrossRef Mistry P, Batchelor H. Methodology used to assess acceptability of oral pediatric medicines: a systematic literature search and narrative review. Paediatr Drugs. 2017;19(3):223–33.PubMedCrossRef
Metadata
Title
Assessment of Taste and Grittiness of Riomet® ER Strawberry, Riomet® ER Grape, Riomet® Cherry, and Metformin Immediate-Release Tablets in Healthy Subjects
Authors
Allyson C. Marshall
Maureen Damstra
Michael Tuley
Elena L. Schifando
Publication date
01-03-2019
Publisher
Springer International Publishing
Keyword
Metformin
Published in
Drugs in R&D / Issue 1/2019
Print ISSN: 1174-5886
Electronic ISSN: 1179-6901
DOI
https://doi.org/10.1007/s40268-018-0260-x

Other articles of this Issue 1/2019

Drugs in R&D 1/2019 Go to the issue